ExagenXGN
13F holders, Q1 2024 (March 31)31holders
3famous investors
$1.59avg. 13F price*
At the end of Q1 2024, 31 institutions reported holding Exagen Inc. (XGN) in their 13F filings. The largest holders were RTW Investments, LP ($2.4M), Cowen and Company, LLC ($1.4M) and Wasatch Advisors LP ($1.3M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Exagen Inc.
- CUSIP
- 30068X103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $29K |
| Exits | 0 | $0 |
Ownership 31 holders
| RTW Investments, LP | 0.04% | No change | 1,504,602 | $2.4M |
| Cowen and Company, LLC | 0.06% | No change | 898,630 | $1.4M |
| Wasatch Advisors LP | 0.01% | Reduce -7.5% | 786,895 | $1.3M |
| Silvercrest Asset Management Group LLC | 0.01% | No change | 544,877 | $866K |
| Perkins Capital Management Inc. | 0.65% | Reduce -3.0% | 493,571 | $785K |
| Vanguard Group Inc. | 0.00% | No change | 490,944 | $781K |
| Morgan Stanley | 0.00% | Reduce -0.3% | 482,420 | $767K |
| Stonepine Capital Management, LLC | 0.49% | Reduce -42.6% | 384,600 | $612K |
| Geode Capital Management, LLC | 0.00% | No change | 81,583 | $130K |
| Penbrook Management LLC | 0.08% | Add +1.3% | 76,710 | $122K |
| Nantahala Capital Management, LLC | 0.01% | Reduce -23.5% | 74,306 | $118K |
| UBS Group AG | 0.00% | Add +0.2% | 62,516 | $99K |
| BlackRock Inc. | 0.00% | Reduce -4.0% | 55,505 | $88K |
| Renaissance Technologies | 0.00% | Add +7.2% | 48,758 | $78K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 40,800 | $65K |
| State Street Corp. | 0.00% | Reduce -17.8% | 27,691 | $44K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -26.6% | 26,437 | $42K |
| Millennium Management | 0.00% | Add +1.0% | 23,860 | $38K |
| Prudential Financial Inc. | 0.00% | Add +86.8% | 19,800 | $31K |
| Palumbo Wealth Management LLC | 0.01% | New | 18,241 | $29K |
| Northern Trust Corp. | 0.00% | Reduce -0.4% | 16,370 | $26K |
| First Bank & Trust | 0.00% | No change | 13,518 | $21K |
| Citadel Advisors | 0.00% | Reduce -65.1% | 7,240 | $12K |
| Allworth Financial LP | 0.00% | No change | 7,015 | $11K |
| Bank of America Corp. | 0.00% | Reduce -0.1% | 6,019 | $10K |
| Barclays PLC | 0.00% | No change | 5,145 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -19.1% | 4,006 | $6K |
| Wells Fargo & Company | 0.00% | Add +0.0% | 2,457 | $4K |
| Qube Research & Technologies Ltd | 0.00% | No change | 204 | $324 |
| JPMorgan Chase & Co. | 0.00% | Add +36.0% | 34 | $54 |
| Royal Bank of Canada | 0.00% | Reduce -83.8% | 88 | $0 |
"% of holder's portfolio" is XGN's weight in each manager's 13F, not the share of Exagen Inc. the manager owns.